Publikationen von Luca Zinzula

Zinzula, L.; Beck, F.; Camasta, M.; Bohn, S.; Liu, C.; Morado, D.; Bracher, A.; Plitzko, J. M.; Baumeister, W.: Cryo-EM structure of single-layered nucleoprotein-RNA complex from Marburg virus. Nature Communications 15 (1), 10307 (2024)

Vickos, U.; Camasta, M.; Grandi, N.; Scognamiglio, S.; Schindler, T.; Belizaire, M. R. D.; Lango-Yaya, E.; Koyaweda, G. W.; Senzongo, O.; Pounguinza, S. et al.; Estime, K. K. J. F.; N'yetobouko, S.; Gadia, C. L. B.; Feiganazoui, D.-A.; Le Faou, A.; Orsini, M.; Perno, C. F.; Zinzula, L.; Rafai, C. D.: COVID-19 Genomic Surveillance in Bangui (Central African Republic) Reveals a Landscape of Circulating Variants Linked to Validated Antiviral Targets of SARS-CoV-2 Proteome. Viruses 15 (12), 2309 (2023)

Zinzula, L.; Scholz, J.; Nagy, I.; Di Guardo, G.; Orsini, M.: Biophysical characterization of the cetacean morbillivirus haemagglutinin glycoprotein. Virus Research 336, 199231 (2023)

Boniardi, I.; Corona, A.; Basquin, J.; Basquin, C.; Milia, J.; Nagy, I.; Tramontano, E.; Zinzula, L.: Suramin inhibits SARS-CoV-2 nucleocapsid phosphoprotein genome packaging function. Virus Research 336, 199221 (2023)

Zinzula, L.; Mereu, A. M.; Orsini, M.; Seeleitner, C.; Bracher, A.; Nagy, I.; Baumeister, W.: Ebola and Marburg virus VP35 coiled-coil validated as antiviral target by tripartite split-GFP complementation. iScience 25 (11), 105354 (2022)

Orsini, M.; Ianni, A.; Zinzula, L.: Brucella ceti and Brucella pinnipedialis genome characterization unveil genetic features that highlight their zoonotic potential. MicrobiologyOpen 11 (5), e1329 (2022)

Corona, A.; Fanunza, E.; Salata, C.; Morwitzer, M. J.; Distinto, S.; Zinzula, L.; Sanna, C.; Frau, A.; Daino, G. L.; Quartu, M. et al.; Taglialatela-Scafati, O.; Rigano, D.; Reid, S.; Mirazimi, A.; Tramontano, E.: Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production. Antiviral Research 198, 105251 (2022)

Zinzula, L.; Mazzariol, S.; Di Guardo, G.: Molecular signatures in cetacean morbillivirus and host species proteomes: Unveiling the evolutionary dynamics of an enigmatic pathogen? Microbiology and Immunology 66 (2), S. 52 - 58 (2022)

Martinez Sanchez, A.; Laugks, U.; Kochovski, Z.; Papantoniou, C.; Zinzula, L.; Baumeister, W.; Lucic, V.: Trans-synaptic assemblies link synaptic vesicles and neuroreceptors. Science Advances 7 (10), eabe6204 (2021)

Stukalov, A.; Girault, V.; Grass, V.; Karayel, O.; Bergant, V.; Urban, C.; Haas, D. A.; Huang, Y.; Oubraham, L.; Wang, A. et al.; Hamad, M. S.; Piras, A.; Hansen, F. M.; Tanzer, M. C.; Paron, I.; Zinzula, L.; Engleitner, T.; Reinecke, M.; Lavacca, T. M.; Ehmann, R.; Woelfel, R.; Jores, J.; Kuster, B.; Protzer, U.; Rad, R.; Ziebuhr, J.; Thiel, V.; Scaturro, P.; Mann, M.; Pichlmair, A.: Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature 594 (7862), S. 246 - 252 (2021)

Zinzula, L.: Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2. Biochemical and Biophysical Research Communications 538, S. 116 - 124 (2021)

Zinzula, L.; Basquin, J.; Bohn, S.; Beck, F.; Klumpe, S.; Pfeifer, G.; Nagy, I.; Bracher, A.; Hartl, F. U.; Baumeister, W.: High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2 acute respiratory syndrome coronavirus 2. Biochemical and Biophysical Research Communications 538, S. 54 - 62 (2021)

Zinzula, L.; Beck, F.; Klumpe, S.; Bohn, S.; Pfeifer, G.; Bollschweiler, D.; Nagy, I.; Plitzko, J. M.; Baumeister, W.: Cryo-EM structure of the cetacean morbillivirus nucleoprotein-RNA complex. Journal of Structural Biology 213 (3), 107750 (2021)

Nagy, I.; Sun, N.; Varga, S.; Boicu, M.; Zinzula, L.; Kukolya, J.: Proteomics Analysis of Thermoplasma Quinone Droplets. Proteomics 19 (3), 1800317 (2019)

Zinzula, L.; Nagy, I.; Orsini, M.; Weyher-Stingl, E.; Bracher, A.; Baumeister, W.: Structures of Ebola and Reston Virus VP35 Oligomerization Domains and Comparative Biophysical Characterization in All Ebolavirus Species. Structure 27 (1), S. 39 - 54.e6 (2019)

Daino, G. L.; Frau, A.; Sanna, C.; Rigano, D.; Distinto, S.; Madau, V.; Espoito, F.; Fanunza, E.; Bianco, G.; Taglialatela-Scafati, O. et al.; Zinzula, L.; Maccioni, E.; Corona, A.; Tramontano, E.: Identification of Myricetin as an Ebola Virus VP35-Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay. Biochemistry 57 (44), S. 6367 - 6378 (2018)

Varga, S.; Pathare, G. R.; Baka, E.; Boicu, M.; Kriszt, B.; Szekacs, A.; Zinzula, L.; Kukolya, J.; Nagy, I.: Enhancing recombinant protein solubility with ubiquitin-like small archeal modifying protein fusion partners. JOURNAL OF MICROBIOLOGICAL METHODS 118, S. 113 - 122 (2015)

Di Palma, F.; Ramaswamy, V. K.; Daino, G.; Frau, A.; Corona, A.; Zinzula, L.; Tramontano, E.; Ruggerone, P.; Vargiu, A.: Insights into Ebola VP35 oligomerization from molecular simulations. In Abstracts of Papers of the American Chemical Society, 255, 356. 255th National Meeting and Exposition of the American-Chemical-Society (ACS) - Nexus of Food, Energy, and Water, New Orleans, LA, 18. März 2018 - 22. März 2018. (2018)